PolyNovo Limited logo

PolyNovo Limited

HQ Melbourne, Australia · Carlsbad

Mission

Our mission is to bring disruptive technologies to market by partnering with the best minds to improve patient outcomes and reimagine the standard of care.

Health & BiotechIndependently selected by SlideDoor

Products and services

  • NovoSorb BTM
  • NovoSorb MTX
  • Burn reconstruction products
  • Surgical wound products

PolyNovo develops and sells biodegradable medical devices based on NovoSorb polymers for burns, wounds and soft-tissue reconstruction.

250–500 peopleFounded 1998

What stands out for senior leaders

We selected PolyNovo Limited for its focus on improving patient outcomes and reimagining the standard of care. Its mission connects disruptive technologies with collaboration among the best minds, giving the business a purpose beyond commercial performance. For a senior leader, that combination makes it worth closer attention.

PolyNovo reported A$150M in revenue for FY2026 and is publicly listed on the ASX as PNV, providing tangible commercial substance alongside its mission. Led by CEO Bruce Peatey, the Melbourne-based company has offices in Melbourne and Carlsbad. In our judgement, its appeal lies in the intersection of health technology, commercial scale and public-market accountability.

Leadership areas

  • Commercial & Sales
  • Operations & Strategy
  • Finance & Capital

The honest trade-off

PolyNovo may not suit leaders who prefer a privately held business rather than a publicly listed environment. Those less drawn to patient outcomes and health technology may also find its mission less aligned with their interests.

Questions leaders ask about PolyNovo Limited

Who leads PolyNovo Limited, and where is it based?
Bruce Peatey is CEO. PolyNovo is based in Melbourne, Australia, with offices in Melbourne and Carlsbad.
What is PolyNovo's scale and listing status?
PolyNovo is publicly listed on the ASX as PNV. It reported A$150M in revenue for FY2026 and has a headcount band of 250–500.
What is PolyNovo's mission?
Its mission is to bring disruptive technologies to market by partnering with the best minds to improve patient outcomes and reimagine the standard of care.

Sources

Last checked November 2026

Headquarters
Melbourne, Australia
CEO
Bruce Peatey
Founded
1998
People
250–500
Stage
Publicly listed (ASX: PNV)
Market cap
A$615M (6 November 2026)
Revenue
A$150M (FY2026)
Offices
Melbourne, Carlsbad

Checked against a public source

Website

More companies in Melbourne